Trial
NCT05053321
Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Neurocrine Biosciences
Condition
Tardive Dyskinesia
Intervention
Valbenazine
Why stopped
Lack of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-11